Alicia Heyward
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alicia Heyward has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Anna Maria Hibbs
Division of Neonatology, University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, USA
2 shared publicationsLulu Zhao
Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, Cleveland, USA
2 shared publications- Moira Crowley
Department of Neonatology, University Hospitals Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, OH 44106, USA
2 shared publications - Nori Minich
School of Medicine, The Case Western Reserve University, Cleveland, OH 44106, USA
2 shared publications Adriana C. Hoffman
Case Western Reserve University School of Medicine, Cleveland, USA
1 shared publicationAdriana Hoffman
University Hospitals Rainbow Babies & Children’s Hospital and Case Western Reserve University School of Medicine
1 shared publication
Latest Publications
- 15 May 2023
- Published by Springer Nature in Journal of Perinatology
- Vol. 43 (7) , 909-915
Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era
Objective Compare Neonatal Opioid Withdrawal Syndrome (NOWS) in preterm and term infants. Study design Single center, retrospective chart review of all in-utero opioid exposed infants born between 2014 and 2019. Withdrawal symptoms were assessed using Modified Finnegan Assessment Tool. Results Thirteen preterm (PT), 72 late preterm (LPT), and 178 term infants were included. Preterm and LPT compared to term infants had lower peak Finnegan scores (9/9 vs. 12) and received less pharmacologic treatment (23.1/44.4 vs. 66.3%). Similar onset, peak symptoms, and treatment duration was observed in LPT and term infants. Conclusions Preterm and LPT infants have lower Finnegan scores and require less pharmacologic therapy for NOWS. It is unclear if this is because our current assessment tool does not capture their symptoms or if they truly have less withdrawal. Onset of NOWS is similar in LPT and term infant, thus LPT infants do not require prolonged hospital monitoring for NOWS.
- 15 May 2023
- Published by Springer Nature in Journal of Perinatology
- Vol. 43 (7) , 909-915
Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era
Objective Compare Neonatal Opioid Withdrawal Syndrome (NOWS) in preterm and term infants. Study design Single center, retrospective chart review of all in-utero opioid exposed infants born between 2014 and 2019. Withdrawal symptoms were assessed using Modified Finnegan Assessment Tool. Results Thirteen preterm (PT), 72 late preterm (LPT), and 178 term infants were included. Preterm and LPT compared to term infants had lower peak Finnegan scores (9/9 vs. 12) and received less pharmacologic treatment (23.1/44.4 vs. 66.3%). Similar onset, peak symptoms, and treatment duration was observed in LPT and term infants. Conclusions Preterm and LPT infants have lower Finnegan scores and require less pharmacologic therapy for NOWS. It is unclear if this is because our current assessment tool does not capture their symptoms or if they truly have less withdrawal. Onset of NOWS is similar in LPT and term infant, thus LPT infants do not require prolonged hospital monitoring for NOWS.
- Open Access
- 13 July 2022
- Published by Springer Nature in Research Square
Characteristics and Outcomes of Neonatal Opioid Withdrawal Syndrome in Preterm Infants: A retrospective cohort study in the current era
OBJECTIVE: Compare Neonatal Opioid Withdrawal Syndrome (NOWS) in preterm and term infants. STUDY DESIGN: Single center, retrospective chart review of all in-utero opioid exposed infants born between 2014 and 2019. Withdrawal symptoms were assessed using Modified Finnegan Assessment Tool. RESULTS: Thirteen preterm (PT), 72 late preterm (LPT), and 178 term infants were included. Preterm and LPT compared to term infants had lower peak Finnegan scores (9/9 vs. 12) and received less pharmacologic treatment (23.1/22.4 vs. 66.3%). Similar onset, peak symptoms, and treatment duration was observed in LPT and term infants. CONCLUSIONS: Preterm and LPT infants have lower Finnegan scores and require less pharmacologic therapy for NOWS. It is unclear if this is because our current assessment tool does not capture their symptoms or if they truly have less withdrawal. Onset of NOWS is similar in LPT and term infant, thus LPT infants do not require prolonged hospital monitoring for NOWS.
- 13 July 2022
- Published by Springer Nature in Research Square
Open AccessCharacteristics and Outcomes of Neonatal Opioid Withdrawal Syndrome in Preterm Infants: A retrospective cohort study in the current era
OBJECTIVE: Compare Neonatal Opioid Withdrawal Syndrome (NOWS) in preterm and term infants. STUDY DESIGN: Single center, retrospective chart review of all in-utero opioid exposed infants born between 2014 and 2019. Withdrawal symptoms were assessed using Modified Finnegan Assessment Tool. RESULTS: Thirteen preterm (PT), 72 late preterm (LPT), and 178 term infants were included. Preterm and LPT compared to term infants had lower peak Finnegan scores (9/9 vs. 12) and received less pharmacologic treatment (23.1/22.4 vs. 66.3%). Similar onset, peak symptoms, and treatment duration was observed in LPT and term infants. CONCLUSIONS: Preterm and LPT infants have lower Finnegan scores and require less pharmacologic therapy for NOWS. It is unclear if this is because our current assessment tool does not capture their symptoms or if they truly have less withdrawal. Onset of NOWS is similar in LPT and term infant, thus LPT infants do not require prolonged hospital monitoring for NOWS.